Literature DB >> 21952537

Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects.

J Norberg1, C Graff, O Almkvist, M Ewers, G B Frisoni, L Frölich, H Hampel, R W Jones, P G Kehoe, H Lenoir, L Minthon, F Nobili, M Olde Rikkert, A-S Rigaud, P Scheltens, H Soininen, L Spiru, M Tsolaki, L-O Wahlund, B Vellas, G Wilcock, L S Elias-Sonnenschein, F R J Verhey, P J Visser.   

Abstract

BACKGROUND: The APOE ε4 allele is a risk factor for Alzheimer's disease (AD). APOE ε4 is common in non-demented subjects with cognitive impairment. In both healthy people and people with AD, its prevalence has a north-south gradient across Europe. In the present study, we investigated whether the relation between the APOE ε4 allele and cognitive impairment varied across Northern, Middle and Southern Europe. We also investigated whether a north-south gradient existed in subjects with subjective cognitive impairment (SCI), amnestic mild cognitive impairment (MCI) and non-amnestic MCI.
METHODS: Data from 16 centers across Europe were analyzed.
RESULTS: A north-south gradient in APOE ε4 prevalence existed in the total sample (62.7% for APOE ε4 carriers in the northern region, 42.1% in the middle region, and 31.5% in the southern region) and in subjects with SCI and amnestic MCI separately. Only in Middle Europe was the APOE ε4 allele significantly associated with poor performance on tests of delayed recall and learning, as well as with the amnestic subtype of MCI.
CONCLUSION: The APOE ε4 allele frequencies in subjects with SCI and amnestic MCI have a north-south gradient. The relation between the APOE ε4 allele and cognition is region dependent.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952537     DOI: 10.1159/000330492

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  7 in total

1.  The number of cysteine residues per mole in apolipoprotein E affects systematically synchronous neural interactions in women's healthy brains.

Authors:  Arthur C Leuthold; Margaret Y Mahan; John J Stanwyck; Angeliki Georgopoulos; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2013-03-17       Impact factor: 1.972

2.  Genetic testing in combination with preventive donepezil treatment for patients with amnestic mild cognitive impairment: an exploratory economic evaluation of personalized medicine.

Authors:  Sandjar Djalalov; Jean Yong; Jaclyn Beca; Sandra Black; Gustavo Saposnik; Zahra Musa; Katherine Siminovitch; Myla Moretti; Jeffrey S Hoch
Journal:  Mol Diagn Ther       Date:  2012-12       Impact factor: 4.074

3.  Apolipoprotein E4 effects on topological brain network organization in mild cognitive impairment.

Authors:  Gretel Sanabria-Diaz; Lester Melie-Garcia; Bogdan Draganski; Jean-Francois Demonet; Ferath Kherif
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

4.  Genetic Effects of NDUFAF6 rs6982393 and APOE on Alzheimer's Disease in Chinese Rural Elderly: A Cross-Sectional Population-Based Study.

Authors:  Yingzhe Cheng; Yuanjing Li; Xiaoyan Liang; Pin Wang; Wenxin Fa; Cuicui Liu; Yongxiang Wang; Keke Liu; Nan Wang; Yifeng Du
Journal:  Clin Interv Aging       Date:  2022-02-24       Impact factor: 4.458

5.  Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Andreas Giannisis; Asma Al-Grety; Henrik Carlsson; Kalicharan Patra; Daniel Twohig; Sigrid Botne Sando; Camilla Lauridsen; Guro Berge; Gøril Rolfseng Grøntvedt; Geir Bråthen; Linda R White; Kim Kultima; Henrietta M Nielsen
Journal:  Alzheimers Res Ther       Date:  2022-08-24       Impact factor: 8.823

6.  Postmenopausal cognitive changes and androgen levels in the context of apolipoprotein E polymorphism.

Authors:  Iwona Bojar; Jarosław Pinkas; Mariusz Gujski; Alfred Owoc; Dorota Raczkiewicz; Kasia Gustaw-Rothenberg
Journal:  Arch Med Sci       Date:  2016-10-10       Impact factor: 3.318

7.  Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.

Authors:  Hanna Cho; Young-Eun Kim; Chang-Seok Ki; Sang Won Seo; Wonjeong Chae; Ko Woon Kim; Jong-Won Kim; Hee Jin Kim; Duk L Na
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.